liver cancer
No description yet: the sentence for this tag has not been written. 5 records carry it: 5 people.
Related tags
5 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Bruno Sangro Translational Research lead, Executive Committee · Cancer Center Clínica Universidad de Navarra / CIMA Hepatologist at Clínica Universidad de Navarra and a leading international investigator in liver cancer systemic therapy and radioembolisation. | Hepatocellular carcinoma, Biliary tract cancer | none | clinician-scientist, immunotherapy | ||
Jia Fan President, Zhongshan Hospital, Fudan University; Liver Cancer Institute · Zhongshan Hospital, Fudan University Jia Fan leads one of the world's busiest liver cancer surgery and transplant programmes and the proteogenomic studies that mapped how hepatitis B-related liver cancer differs at the molecular level. | Hepatocellular carcinoma, Biliary tract cancer | none | china, leadership, clinician-scientist | ||
Josep M. Llovet Director, Liver Cancer Program, Icahn School of Medicine at Mount Sinai; Professor, University of Barcelona · The Mount Sinai Hospital / Tisch Cancer Institute Led SHARP, which made sorafenib the first systemic therapy for liver cancer, and created the BCLC staging system. | Hepatocellular carcinoma | none | hcc, staging, trialist | ||
Kenneth K. Tanabe President · Society of Surgical Oncology Massachusetts General Hospital surgical oncologist and 2026-2027 President of the Society of Surgical Oncology, with expertise in liver cancer and melanoma. | Hepatocellular carcinoma, Melanoma | none | leadership, clinician-scientist, surgical oncology | ||
Lars Zender Deputy Speaker; Medical Director, Internal Medicine VIII (Medical Oncology and Pulmonology) · Comprehensive Cancer Center Tübingen-Stuttgart Medical oncologist and cancer biologist at Tübingen, known for work on senescence surveillance and functional genomics in liver cancer. | Hepatocellular carcinoma | none | leadership, clinician-scientist, cancer biology |
